US FDA Approves Zydus Lifesciences’ Tavaborole Topical Solution

Zydus Lifesciences Ltd., a Canadian pharmaceutical manufacturer, announced on Friday that the United States Food and Drug Administration (USFDA) has granted final approval for the production and distribution of Tavaborole Topical Solution 5%. According to the company’s exchange filing, Tavaborole topical solution is indicated for the treatment of fungal toenail infections, infections that can cause […]

Continue Reading

US FDA Approved Zydus Lifesciences’ Generic Drug to Treat Myxedema Coma

As per a financial exchange documenting, Zydus Lifesciences Restricted, previously Cadila Medical services Restricted, has gotten endorsement from the US wellbeing controller to showcase a conventional item. In a BSE statement, the company said that Zydus has received final approval from the United States Food and Drug Administration (USFDA) for levothyroxine sodium for injection, 100 […]

Continue Reading

US FDA Approves Generic Hypertension Drug of Zydus Lifesciences

The US Food and Drug Administration (FDA) has approved Zydus Lifesciences’ hypertension drugs Bisoprolol Fumrate and Hydrochlorothiazide tablets in the United States. The US FDA has given clearance to Zydus Lifesciences to market generic medicines in the United States in multiple strengths. With increasing cases of hypertension, the combination of Bisoprolol Fumrate and hydrochlorothiazide is […]

Continue Reading

US FDA Approves Type 2 Diabetes Drug by Zydus Lifesciences

Zydus Lifesciences announced that it has now received final approval from the Food and Drug Administration (FDA) of the United States to market Empagliflozin and Metformin Hydrochloride tablets. The Empagliflozin and Metformin Hydrochloride tablets are used with exercise, and proper diet to improve glycemic control in adults with the Type 2 diabetes mellitus. They are […]

Continue Reading